Mr Arvind Shah,
Managing Director and Chief Executive Officer.
Incorporated as a Private Limited Company, we set
out to manufacture and market world-class allopathic
and ayurvedic pharmaceutical products within and
outside India, thus beginning to realize the vision
of bringing high quality healthcare to the common
man. Since then, we have come a long way. Having
grown notably in terms of production capacity, product
categories, market share, advancements in R &
D, market reach and global acceptance, we are today
a significant force to reckon with in the Indian
Pharmaceutical Industry.
We entered the field at a time when the Indian Pharmaceutical
Industry was itself at the threshold of a new era,
where product patenting and holistic healthcare
were gaining prominence. Our core strength aptly
lay in the ability to deliver both Western and Eastern
varieties of quality treatments. Significant contributions
have been made to the fields of Cardiology, Dermatology,
Nephrology and Diabetes among others.
Having established
our credibility as a company committed to providing
world-class healthcare products, we went Public
in April 1996 getting listed in Mumbai, Ahmedabad
and Chennai Stock Exchanges. The Public Issue
comprised of 30 Lakhs Equity Shares priced at
Rs.10/- each at a premium of Rs.20/- per share.
In January 2001, the Company followed this up
with a Rights Issue of 14.86 Lakhs Equity Shares
of Rs.10/- each for cash at a premium of Rs.90/-
per share.
Last fiscal, we registered an Annual Turnover
of Rs.120 crore. We are a Profit-making, Dividend-paying
Company with an Equity Share Capital of Rs.26
crores
Arvind Remedies’ Indian client portfolio
includes prestigious Defence Establishments, ESI,
CGHS, Central and State Government Institutions,
Public Sector Companies, P&T, Railways and
World Bank Projects. We have also won international
acceptance and recognition with our exports to
Africa, Commonwealth of Independent States and
Asian countries.